Rolls-Royce PLC
13 March 2002
13 March 2002
ROLLS-ROYCE WINS $60M GREEK MILITARY ENGINE ORDER
Rolls-Royce today announced it will provide 24 to 30 AE 2100 engines worth an
estimated $60 million, including spares and initial provisioning, for 12 to 15
Alenia-Lockheed Martin twin-engined C-27J Spartan transport aircraft for the
Greek Armed Forces.
The 4637 shp Rolls-Royce engines are designed and produced at the Rolls-Royce
facilities in Indianapolis, Indiana, U.S. They are close derivatives of the
engines powering the Lockheed Martin C-130J , being introduced into service in
the U.S., UK, and Australia.
For further information please contact:
Justine Steele
Head of Communications - Defence
Rolls-Royce plc
Tel: 0117 979 1234
Fax: 0117 979 7788
Email: justine.steele@rolls-royce.com
This information is provided by RNS
The company news service from the London Stock Exchange
UGDXDDBGGDX
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.